The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: A post hoc analysis of the MADIAB trial

BMJ Open Diabetes Research and Care

Volumn 3, Issue 1, 2015, Pages

  Soare, Andreea ^a   Toro, Rossella Del ^a   Roncella, Elena ^a   Khazrai, Yeganeh Manon ^a   Angeletti, Silvia ^a   Dugo, Laura ^a   Fallucca, Sara ^a   Fontana, Lucia ^b   Altomare, Maria ^b   Formisano, Valeria ^a   Capata, Francesca ^a   Gesuita, Rosaria ^c   Manfrini, Silvia ^a   Fallucca, Francesco ^d   Pianesi, Mario ^e   Pozzilli, Paolo ^a,f  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SANDRO PERTINI HOSPITAL   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Agriculture   (Italy)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY FIBER; ENZYME ASSAY; FEMALE; HIP CIRCUMFERENCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MACROBIOTIC DIET; MACROBIOTIC MA PI 2 DIET; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDOMETER; PHYSICAL ACTIVITY; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN INTAKE; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE;

EID: 85006141161     PISSN: None     EISSN: 20524897     Source Type: Journal    
DOI: 10.1136/bmjdrc-2014-000079     Document Type: Article

References (35)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
2. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7.
3. Herder C, Schneitler S, Rathmann W, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 2007;92:4569-74.
4. Shea S, Aymong E, Zybert P, et al. Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. Obes Res 2003;11:95-103.
5. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-30.
6. Kern PA, Ranganathan S, Li C, et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Renal Physiol 2001;280:E745-51.
7. van Hall G, Steensberg A, Sacchetti M, et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 2003;88:3005-10.
8. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
9. Frei B, Higdon JV. Obesity and oxidative stress: a direct link to CVD? Arterioscler Thromb Vasc Biol 2003;23:365-7.
10. Kelishadi R, Hashemi M, Mohammadifard N, et al. Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clin Chem 2008;54:147-53.
11. Kim MK, Cho SW, Park YK. Long-term vegetarians have low oxidative stress, body fat, and cholesterol levels. Nutr Res Pract 2012;6:155-61.
12. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996;239:70-6.
13. Pinto A, Toselli L, Gavarini G, et al. Dieta, infiammazione e malattie metaboliche. L 'Endocrinologo 2014;15:16-21.
14. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011;29:415-45.
15. Salas-Salvadó J, Martinez-González MA, Bulló M, et al. The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis 2011;21:B32-48.
16. Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 2002;13:3-9.
17. Hoffmann K, Schulze MB, Schienkiewitz A, et al. Application of a new statistical method to derive dietary patterns in nutritional epidemiology. Am J Epidemiol 2004;159:935-44.
18. Barbaresko J, Koch M, Schulze MB, et al. Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutr Rev 2013;71:511-27.
19. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006;48:677-85.
20. Qi L, Meigs JB, Liu S, et al. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care 2006;29:1501-5.
21. Ma Y, Griffith JA, Chasan-Taber L, et al. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 2006;83:760-6.
22. Ajani UA, Ford ES, Mokdad AL. Dietary fiber and C reactive protein findings from National Health Nutrition Examination Survey data. J Nutr 2004;134:1181-5.
23. Soare A, Khazrai YM, Del Toro R, et al; for the MADIAB Group. The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial. Nutr Metab 2014;11:39.
24. Associazione Medici Diabetologici, Società Italiana di Diabetologia (Ed). Standard italiani per la cura del diabete mellito. Torino: Edizione per la Medicina Generale Infomedica, 2011.
25. Turner L, Shamseer L, Altman DG, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published. Cochrane Database Syst Rev 2012;11:MR000030.
26. Gnagnarella P, Parpinel M, Salvini S, et al. The update of the Italian Food Composition Database. J Food Composition Anal 2004;17:509-22.
27. Porrata-Maury C, Hernández-Triana M, Ruiz-Alvarez V, et al. Ma-Pi 2 macrobiotic diet and type 2 diabetes mellitus: pooled analysis of short-term intervention studies. Diabetes Metab Res Rev 2014;30:55-66.
28. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
29. Bartlett HE, Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt 2008;28:503-23.
30. Priebe MG, van Binsbergen JJ, de Vos R, et al. Whole grain foods for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 2008;CD006061. DOI: 10.1002/14651858.CD006061.pub2
31. Gao X, Bermudez OI, Tucker KL. Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J Nutr 2004;134:913-18.
32. Aune D, Norat T, Romundstad P, et al. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Eur J Epidemiol 2013;28:845-58.
33. Jenkins DJ, Kendall CW, Faulkner DA, et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr 2006;83:582-91.
34. Liu K, Zhou R, Wang B, et al. Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr 2013;98:340-8.
35. Hanhineva K, Törrönen R, Bondia-Pons I, et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010;11:1365-402.